{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T13:58:40Z","timestamp":1784901520338,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T00:00:00Z","timestamp":1557964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T00:00:00Z","timestamp":1557964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although a variety of animal models of atherosclerosis have been developed, these models are time-consuming and costly. Here, we describe an <jats:italic>in vitro<\/jats:italic> model to induce foam cell formation in the early stage of atherosclerosis. This model is based on a three-dimension co-culture system in a stretchable microfluidic device. An elastic membrane embedded in the microfluidic device is capable of delivering nonuniform strain to vascular smooth muscle cells, endothelial cells and monocytes adhering thereto, which are intended to mimic the biological environment of blood vessels. Under low-density lipoprotein and stretch treatment, foam cell formation was successfully induced in co-culture with changes in mRNA and protein expression of some related key factors. Subsequently, the model was used to assess the inhibitory effect of atorvastatin on foam cell formation. The results obtained indicate that atorvastatin has a significantly dose-dependent inhibition of foam cell formation, which can be explained by the changes in mRNA and protein expression of the related factors. In principle, the model can be used to study the role of different types of cells in the formation of foam cells, as well as the evaluation of anti-atherosclerotic drugs.<\/jats:p>","DOI":"10.1038\/s41598-019-43902-3","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T10:05:46Z","timestamp":1558001146000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["An in vitro model of foam cell formation induced by a stretchable microfluidic device"],"prefix":"10.1038","volume":"9","author":[{"given":"Xiaoyang","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijie","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,16]]},"reference":[{"key":"43902_CR1","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1161\/01.ATV.19.8.1819","volume":"19","author":"G Assmann","year":"1999","unstructured":"Assmann, G., Cullen, P., Jossa, F., Lewis, B. & Mancini, M. Coronary heart disease: reducing the risk: the scientific background to primary and secondary prevention of coronary heart disease. A worldwide view. International Task force for the Prevention of Coronary Heart disease. Arterioscler. Thromb. Vasc. Biol. 19, 1819\u20131824 (1999).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"43902_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/35025203","volume":"407","author":"AJ Lusis","year":"2000","unstructured":"Lusis, A. J. Atherosclerosis. Nature. 407, 233\u2013241 (2000).","journal-title":"Nature."},{"key":"43902_CR3","doi-asserted-by":"publisher","first-page":"III-27-III-32","DOI":"10.1161\/01.CIR.0000131890.83839.5B","volume":"109","author":"J Davignon","year":"2004","unstructured":"Davignon, J. & Ganz, P. Role of endothelial dysfunction in atherosclerosis. Circulation. 109, III-27-III-32 (2004).","journal-title":"Circulation."},{"key":"43902_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.cmet.2009.08.004","volume":"10","author":"M Sekiya","year":"2009","unstructured":"Sekiya, M. et al. Ablation of neutral cholesterol ester hydrolase 1 accelerates atherosclerosis. Cell Metab. 10, 219\u2013228 (2009).","journal-title":"Cell Metab."},{"key":"43902_CR5","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1172\/JCI30485","volume":"117","author":"B Zhao","year":"2007","unstructured":"Zhao, B. et al. Macrophage-specific transgenic expression of cholesteryl ester hydrolase significantly reduces atherosclerosis and lesion necrosis in Ldlr\u2212\/\u2212mice. J. Clin Invest. 117, 2983\u20132992 (2007).","journal-title":"J. Clin Invest."},{"key":"43902_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cca.2013.06.006","volume":"424","author":"XH Yu","year":"2013","unstructured":"Yu, X. H., Fu, Y. C., Zhang, D. W., Yin, K. & Tang, C. K. Foam cells in atherosclerosis. Clin. Chim. Acta. 424, 245\u2013252 (2013).","journal-title":"Clin. Chim. Acta."},{"key":"43902_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/jcmm.12689","volume":"20","author":"DA Chistiakov","year":"2016","unstructured":"Chistiakov, D. A., Bobryshev, Y. V. & Orekhov, A. N. Macrophage\u2010mediated cholesterol handling in atherosclerosis. J. Cell. Mol. Med. 20, 17\u201328 (2016).","journal-title":"J. Cell. Mol. Med."},{"key":"43902_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.pharmthera.2014.09.009","volume":"146","author":"J Fan","year":"2015","unstructured":"Fan, J. et al. Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine. Pharmacol. Ther. 146, 104\u2013119 (2015).","journal-title":"Pharmacol. Ther."},{"key":"43902_CR9","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1126\/science.aaf6659","volume":"354","author":"BG Childs","year":"2016","unstructured":"Childs, B. G. et al. Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science. 354, 472\u2013477 (2016).","journal-title":"Science."},{"key":"43902_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.atherosclerosis.2018.02.015","volume":"271","author":"Y Zhao","year":"2018","unstructured":"Zhao, Y. et al. Hyperlipidemia induces typical atherosclerosis development in Ldlr and Apoe deficient rats. Atherosclerosis. 271, 26\u201335 (2018).","journal-title":"Atherosclerosis."},{"key":"43902_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/path.4646","volume":"238","author":"J Shim","year":"2016","unstructured":"Shim, J., Al\u2010Mashhadi, R. H., S\u00f8rensen, C. B. & Bentzon, J. F. Large animal models of atherosclerosis\u2013new tools for persistent problems in cardiovascular medicine. J. Pathol. 238, 257\u2013266 (2016).","journal-title":"J. Pathol."},{"key":"43902_CR12","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/jcb.10583","volume":"89","author":"S Heydarkhan-Hagvall","year":"2003","unstructured":"Heydarkhan-Hagvall, S. et al. Co-culture of endothelial cells and smooth muscle cells affects gene expression of angiogenic factors. J. Cell. Biochem. 89, 1250\u20131259 (2003).","journal-title":"J. Cell. Biochem."},{"key":"43902_CR13","doi-asserted-by":"publisher","first-page":"57929","DOI":"10.1039\/C4RA09416F","volume":"4","author":"V Leszczak","year":"2014","unstructured":"Leszczak, V. & Popat, K. C. Direct co-culture of endothelial and smooth muscle cells on poly(\u03b5-caprolactone) nanowire surfaces. RSC Adv. 4, 57929\u201357934 (2014).","journal-title":"RSC Adv."},{"key":"43902_CR14","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/bph.13371","volume":"173","author":"M Sarwar","year":"2016","unstructured":"Sarwar, M., Samuel, C. S., Bathgate, R. A., Stewart, D. R. & Summers, R. J. Enhanced serelaxin signalling in co-cultures of human primary endothelial and smooth muscle cells. Br. J. Pharmacol. 173, 484\u2013496 (2016).","journal-title":"Br. J. Pharmacol."},{"key":"43902_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nrcardio.2015.203","volume":"13","author":"AJ Brown","year":"2016","unstructured":"Brown, A. J. et al. Role of biomechanical forces in the natural history of coronary atherosclerosis. Nat. Rev. Cardiol. 13, 210\u2013220 (2016).","journal-title":"Nat. Rev. Cardiol."},{"key":"43902_CR16","doi-asserted-by":"crossref","unstructured":"Kwak, B. R. et al. Biomechanical factors in atherosclerosis: mechanisms and clinical implications. Eur. Heart J. 35, 3013\u20133020, 3020a\u20133020d (2014).","DOI":"10.1093\/eurheartj\/ehu353"},{"key":"43902_CR17","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1089\/ars.2009.2908","volume":"13","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y., Peng, F., Gao, B., Ingram, A. J. & Krepinsky, J. C. Mechanical strain-induced RhoA activation requires NADPH oxidase-mediated ROS generation in caveolae. Antioxid Redox Signal. 13, 959\u2013973 (2010).","journal-title":"Antioxid Redox Signal."},{"key":"43902_CR18","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1161\/CIRCRESAHA.114.302157","volume":"114","author":"J Wu","year":"2014","unstructured":"Wu, J. et al. Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 MAP kinase. Circ. Res. 114, 616\u2013625 (2014).","journal-title":"Circ. Res."},{"key":"43902_CR19","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1089\/ars.2013.5517","volume":"20","author":"CW Ward","year":"2014","unstructured":"Ward, C. W., Prosser, B. L. & Lederer, W. J. Mechanical stretch-induced activation of ROS\/RNS signaling in striated muscle. Antioxid Redox Signal. 20, 929\u2013936 (2014).","journal-title":"Antioxid Redox Signal."},{"key":"43902_CR20","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/ncpcardio1211","volume":"5","author":"U F\u00f6rstermann","year":"2008","unstructured":"F\u00f6rstermann, U. Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat. Rev. Cardiol. 5, 338 (2008).","journal-title":"Nat. Rev. Cardiol."},{"key":"43902_CR21","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1089\/ars.2010.3361","volume":"15","author":"J Ando","year":"2011","unstructured":"Ando, J. & Yamamoto, K. Effects of shear stress and stretch on endothelial function. Antioxid Redox Signal. 15, 1389\u20131403 (2011).","journal-title":"Antioxid Redox Signal."},{"key":"43902_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/labinvest.3700215","volume":"85","author":"KS Cunningham","year":"2005","unstructured":"Cunningham, K. S. & Gotlieb, A. I. The role of shear stress in the pathogenesis of atherosclerosis. Lab. Invest. 85, 9\u201323 (2005).","journal-title":"Lab. Invest."},{"key":"43902_CR23","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1161\/CIRCULATIONAHA.105.590018","volume":"113","author":"C Cheng","year":"2006","unstructured":"Cheng, C. et al. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation. 113, 2744\u20132753 (2006).","journal-title":"Circulation."},{"key":"43902_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2015.08.029","volume":"243","author":"A Pfenniger","year":"2015","unstructured":"Pfenniger, A. et al. Shear stress-induced atherosclerotic plaque composition in ApoE\u2212\/\u2212 mice is modulated by connexin37. Atherosclerosis. 243, 1\u201310 (2015).","journal-title":"Atherosclerosis."},{"key":"43902_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.atherosclerosis.2015.04.796","volume":"241","author":"LC Winkel","year":"2015","unstructured":"Winkel, L. C., Hoogendoorn, A., Xing, R., Wentzel, J. J. & Van der Heiden, K. Animal models of surgically manipulated flow velocities to study shear stress-induced atherosclerosis. Atherosclerosis. 241, 100\u2013110 (2015).","journal-title":"Atherosclerosis."},{"key":"43902_CR26","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1039\/C5LC01416F","volume":"16","author":"J Wang","year":"2016","unstructured":"Wang, J., Fan, B., Wei, Y., Suo, X. & Ding, Y. A simple multi-well stretching device to induce inflammatory responses of vascular endothelial cells. Lab chip. 16, 360\u2013367 (2016).","journal-title":"Lab chip."},{"key":"43902_CR27","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/82219","volume":"6","author":"B Kwak","year":"2000","unstructured":"Kwak, B., Mulhaupt, F., Myit, S. & Mach, F. Statins as a newly recognized type of immunomodulator. Nat. Med. 6, 1399 (2000).","journal-title":"Nat. Med."},{"key":"43902_CR28","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1161\/CIRCULATIONAHA.105.568147","volume":"113","author":"A Schmermund","year":"2006","unstructured":"Schmermund, A. et al. Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial. Circulation. 113, 427\u2013437 (2006).","journal-title":"Circulation."},{"key":"43902_CR29","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","volume":"375","author":"N Sattar","year":"2010","unstructured":"Sattar, N. et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet. 375, 735\u2013742 (2010).","journal-title":"Lancet."},{"key":"43902_CR30","doi-asserted-by":"publisher","unstructured":"Taylor, F. et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst. Rev. CD004816, https:\/\/doi.org\/10.1002\/14651858.CD004816.pub5 (2011).","DOI":"10.1002\/14651858.CD004816.pub5"},{"key":"43902_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","volume":"45","author":"JK Liao","year":"2005","unstructured":"Liao, J. K. & Laufs, U. Pleiotropic effects of statins. Annu. Rev. Pharmacol. Toxicol. 45, 89\u2013118 (2005).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"43902_CR32","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1161\/01.CIR.0000138743.09012.93","volume":"110","author":"J Haendeler","year":"2004","unstructured":"Haendeler, J., Hoffmann, J., Zeiher, A. M. & Dimmeler, S. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins. Circulation. 110, 856\u2013861 (2004).","journal-title":"Circulation."},{"key":"43902_CR33","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1161\/hq0202.104081","volume":"22","author":"S Wassmann","year":"2002","unstructured":"Wassmann, S. et al. Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 22, 300\u2013305 (2002).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"43902_CR34","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.atherosclerosis.2009.11.032","volume":"210","author":"XM Bao","year":"2010","unstructured":"Bao, X. M., Wu, C. F. & Lu, G. P. Atorvastatin inhibits homocysteine-induced oxidative stress and apoptosis in endothelial progenitor cells involving Nox4 and p38MAPK. Atherosclerosis. 210, 114\u2013121 (2010).","journal-title":"Atherosclerosis."},{"key":"43902_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05665-7","volume":"7","author":"X Hong","year":"2017","unstructured":"Hong, X. et al. Transdifferentiated human vascular smooth muscle cells are a new potential cell source for endothelial regeneration. Sci. Rep. 7, 5590 (2017).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43902-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43902-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43902-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T09:42:49Z","timestamp":1671270169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-43902-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,16]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["43902"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-43902-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,16]]},"assertion":[{"value":"28 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7461"}}